Skip to content

Clinical trials

Phase 1 Urinary Bladder Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 1 Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20132
20151
20171
20181
20201
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Eli Lilly and Company2
Astellas Pharma Global Development, Inc.1
EMD Serono Research & Development Institute, Inc.1
Genentech, Inc.1
IDEAYA Biosciences1
Lindis Biotech GmbH1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms10
Carcinoma, Transitional Cell4
Carcinoma, Non-Small-Cell Lung3
Non-Muscle Invasive Bladder Neoplasms3
Colorectal Neoplasms2
Head and Neck Neoplasms2
Lung Neoplasms2
Melanoma2
Neoplasm Metastasis2
Neoplasms2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.